C4 Therapeutics Inc (CCCC) — Cash Flow Reinvestment Rate
C4 Therapeutics Inc (CCCC) has a Cash Flow Reinvestment Rate of 0.02x as of June 2019, reinvesting $641.00K (capex $641.00K ) from operating cash flow of $36.91 Million. See CCCC FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
C4 Therapeutics Inc Cash Flow Reinvestment Rate (2019–2019)
Historical reinvestment intensity for C4 Therapeutics Inc across 1 annual periods. For the full cash flow conversion analysis, see how efficiently does C4 Therapeutics Inc generate cash.
Annual Cash Flow Reinvestment Rate for C4 Therapeutics Inc (2019–2019)
Year-by-year capital reinvestment analysis for C4 Therapeutics Inc. See C4 Therapeutics Inc (CCCC) financial flexibility to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2019 | 0.05x | $2.97 Million | $55.61 Million | $1.35 Million | — |